XyloCor Therapeutics, a gene therapy firm, has raised $22.6 million in funding. Fountain Healthcare Partners led the round with participation from other investors that included Longwood Fund, Lumira Ventures, Sofinnova Investments and LSP.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: